Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution

Circulation. 2002 Oct 1;106(14):1859-66. doi: 10.1161/01.cir.0000031334.49170.fb.

Abstract

Background: The combined effects of excitability and action potential duration (APD) restitution on wavefront dynamics remain unclear.

Methods and results: We used optical mapping techniques to study Langendorff-perfused rabbit hearts. In protocol IA (n=10), D600 at increasing concentrations was infused during ventricular fibrillation (VF). With concentration increased to 0.5 mg/L, fast VF (dominant frequency, 19.1+/-1.8 Hz) was consistently converted to ventricular tachycardia (VT). However, increasing D600 further to 2.5 or 5.0 mg/L converted VT to slow VF (11.9+/-2.3 Hz, P=0.0011). In an additional 4 hearts (protocol IB), tetrodotoxin converted a preexisting VT to slow VF (11.0+/-1.4 Hz). Optical maps show wandering wavelets in fast VF, organized reentry in VT, and spatiotemporal periodicity in slow VF. In protocol II, we determined APD and conduction time(-1) (CT(-1)) restitutions during D600 infusion. CT(-1) was used as an estimate of excitability. At 0.1 mg/L, APD and CT(-1) restitutions were steep and flat, respectively. APD restitution became flattened when D600 increased to 0.5 mg/L, converting fast VF to VT. Further increasing D600 to 2.5 or 5.0 mg/L steepened CT(-1) restitution and widened the range of S(1) pacing cycle lengths over which CT(-1) decreased, converting VT to slow VF.

Conclusions: Two types of VF exist in isolated rabbit hearts. Fast (type I) VF is associated with a steep APD restitution, a flat CT(-1) restitution, and wandering wavelets. Slow (type II) VF is associated with a flat APD restitution, a steep CT(-1) restitution, and spatiotemporal periodicity. Both excitability and APD restitution are important in VF maintenance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Action Potentials* / drug effects
  • Action Potentials* / physiology
  • Animals
  • Body Surface Potential Mapping
  • Calcium Channel Blockers / pharmacology
  • Cardiac Pacing, Artificial
  • Dose-Response Relationship, Drug
  • Electrocardiography / drug effects
  • Electrocardiography / methods
  • Electrodes, Implanted
  • Electrophysiologic Techniques, Cardiac*
  • Fluorescent Dyes
  • Fourier Analysis
  • Gallopamil / pharmacology
  • Heart / drug effects
  • Heart / physiopathology*
  • In Vitro Techniques
  • Light
  • Optics and Photonics
  • Pyridinium Compounds
  • Rabbits
  • Sodium Channel Blockers / pharmacology
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / physiopathology
  • Tetrodotoxin / pharmacology
  • Time Factors
  • Ventricular Fibrillation / classification*
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / physiopathology*

Substances

  • Calcium Channel Blockers
  • Fluorescent Dyes
  • Pyridinium Compounds
  • Sodium Channel Blockers
  • Gallopamil
  • Tetrodotoxin
  • 1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine